Cancer; a biological approach. I. The processes of control.
作者信息
BURNET M
出版信息
Br Med J. 1957 Apr 6;1(5022):779-86. doi: 10.1136/bmj.1.5022.779.
Abstract
摘要
相似文献
1
Cancer; a biological approach. I. The processes of control.
Br Med J. 1957 Apr 6;1(5022):779-86. doi: 10.1136/bmj.1.5022.779.
2
Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications.
Br Med J. 1957 Apr 13;1(5023):841-7. doi: 10.1136/bmj.1.5023.841.
3
[Contribution to the problem of the etiology of cancer and outline of a new approach to therapy].
Dia Med. 1952 Sep 18;24(61):1592-4.
4
[Biological therapy for cancer].
Hippokrates. 1956 Jun 15;27(11):346-51.
5
[Some questions on etiology and pathogenesis of cancer].
Vopr Onkol. 1956;2(1):10-8.
6
[Etiology and pathogenesis of cancer according to immunological studies].
Ter Arkh. 1953 Jan-Feb;25(1):90-1.
7
Biological equilibrium and the origin of cancer.
Science. 1957 Mar 29;125(3248):595-6. doi: 10.1126/science.125.3248.595.
8
On the etiology of cancer.
J Chronic Dis. 1958 Jul;8(1):38-57. doi: 10.1016/0021-9681(58)90040-7.
9
[Tumoral processes and characteristics of their pathogenesis].
Vestn Akad Med Nauk SSSR. 1959;14(7):42-50.
10
A physical approach to the problem of cancer.
Br J Cancer. 1954 Jun;8(2):259-73. doi: 10.1038/bjc.1954.27.
引用本文的文献
1
The Bright Future of mRNA as a Therapeutic Molecule.
Genes (Basel). 2025 Mar 26;16(4):376. doi: 10.3390/genes16040376.
2
Advances in research on flavonoids in tumor immunotherapy (Review).
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13515. Epub 2025 Apr 11.
3
Cancer immunotherapy in progress-an overview of the past 130 years.
Int Immunol. 2025 Apr 7;37(5):253-260. doi: 10.1093/intimm/dxaf002.
4
Coley's Toxin to First Approved Therapeutic Vaccine-A Brief Historical Account in the Progression of Immunobiology-Based Cancer Treatment.
Biomedicines. 2024 Nov 30;12(12):2746. doi: 10.3390/biomedicines12122746.
5
Does Asthma Affect the Risk of Developing Breast Cancer?
Cancer Med. 2025 Jan;14(1):e70539. doi: 10.1002/cam4.70539.
6
Thymoma and thymic carcinoma.
Indian J Thorac Cardiovasc Surg. 2024 Nov;40(6):658-659. doi: 10.1007/s12055-024-01768-9. Epub 2024 Jun 4.
7
Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα- and CD24-Siglec10-Mediated Phagocytosis.
J Immunol. 2024 Nov 1;213(9):1279-1291. doi: 10.4049/jimmunol.2400035.
8
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Semin Liver Dis. 2024 May;44(2):159-179. doi: 10.1055/a-2334-8311. Epub 2024 May 28.
9
STINGing Defenses: Unmasking the Mechanisms of DNA Oncovirus-Mediated Immune Escape.
Viruses. 2024 Apr 9;16(4):574. doi: 10.3390/v16040574.
10
Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.
Adv Healthc Mater. 2024 Aug;13(20):e2400323. doi: 10.1002/adhm.202400323. Epub 2024 May 3.
Zotero 插件